Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet therapy for treating HIV infection. This formula combines three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the virus's ability to copy within the body, considerably reducing the viral load. For many in